Pulse Biosciences (NASDAQ:PLSE – Get Free Report) is scheduled to announce its earnings results after the market closes on Tuesday, May 7th. Persons interested in listening to the company’s earnings conference call can do so using this link.
Pulse Biosciences (NASDAQ:PLSE – Get Free Report) last released its earnings results on Thursday, March 28th. The company reported ($0.21) earnings per share for the quarter.
Pulse Biosciences Price Performance
PLSE stock opened at $7.82 on Friday. Pulse Biosciences has a twelve month low of $3.78 and a twelve month high of $13.62. The business’s 50-day simple moving average is $8.53 and its 200 day simple moving average is $8.32.
Pulse Biosciences Company Profile
Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
Further Reading
- Five stocks we like better than Pulse Biosciences
- Retail Stocks Investing, Explained
- MarketBeat Week in Review – 4/29 – 5/3
- Financial Services Stocks Investing
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Stock Average Calculator
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
